What is Wai Yuen Tong Medicine Holdings EV-to-Revenue?
EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Wai Yuen Tong Medicine Holdings's enterprise value is HK$1,375 Mil.
Wai Yuen Tong Medicine Holdings's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 was HK$1,359 Mil. Therefore, Wai Yuen Tong Medicine Holdings's EV-to-Revenue for today is 1.01.
The historical rank and industry rank for Wai Yuen Tong Medicine Holdings's EV-to-Revenue or its related term are showing as below:
HKSE:00897'
s EV-to-Revenue Range Over the Past 10 Years
Min: -0.05 Med: 0.53 Max: 4.56
Current: 1.01
During the past 13 years, the highest EV-to-Revenue of Wai Yuen Tong Medicine Holdings was 4.56. The lowest was -0.05. And the median was 0.53.
HKSE:00897's EV-to-Revenue is ranked better than 77.65% of 1020
companies
in the Drug Manufacturers industry
Industry Median: 2.275
vs HKSE:00897: 1.01
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Wai Yuen Tong Medicine Holdings EV-to-Revenue Chart
Competitive Comparison of Wai Yuen Tong Medicine Holdings's EV-to-Revenue
For the Drug Manufacturers - Specialty & Generic subindustry, Wai Yuen Tong Medicine Holdings's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Wai Yuen Tong Medicine Holdings's EV-to-Revenue Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Wai Yuen Tong Medicine Holdings's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Wai Yuen Tong Medicine Holdings's EV-to-Revenue falls into.
Wai Yuen Tong Medicine Holdings EV-to-Revenue Calculation
Wai Yuen Tong Medicine Holdings's current Enterprise Value is HK$1,375 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Wai Yuen Tong Medicine Holdings's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 was HK$1,359 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Wai Yuen Tong Medicine Holdings (HKSE:00897) EV-to-Revenue Explanation
Wai Yuen Tong Medicine Holdings's share price for today is HK$0.216.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Sep. 2023 was HK$1.14.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Wai Yuen Tong Medicine Holdings EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Wai Yuen Tong Medicine Holdings's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Wai Yuen Tong Medicine Holdings (HKSE:00897) Business Description
Wai Yuen Tong Medicine Holdings Ltd is an investment holding company. The company's operating segment includes production and sale of Chinese pharmaceutical and health food products; production and sale of Western pharmaceutical and health food products and property investment and management and sale of properties in the agricultural produce market. It generates maximum revenue from the production and sale of Chinese pharmaceutical and health food products which include manufacturing, processing, and sale of traditional Chinese medicine which includes Chinese medicinal products sold under the brand name Wai Yuen Tong. Geographically, it derives a majority of revenue from Mainland China.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:00897 has been successfully added to your 